Pixel by LabCorp ℠ Offers Self-Collected Testing Anytime, Anywhere to Empower Healthcare Consumers BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp® (NYSE: LH), a leading global life sciences company, today ...
BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has closed its acquisition of Personal Genome Diagnostics Inc. (PGDx), a leader ...
BURLINGTON, N.C.--(BUSINESS WIRE)-- LabCorp® (NYSE: LH), a leading global life sciences company that is deeply integrated in guiding patient care, today announced that it will mark its 50th ...
“Adding Toxikon underscores our commitment to nonclinical development and advances our capabilities for both drug development and medical device testing,” said Dr. Paul Kirchgraber, CEO of Labcorp ...
Laboratory testing plays a critical role in healthcare, informing nearly 70% of clinical decisions and often serving as the first step in diagnosing and managing patient conditions. Yet research shows ...
Restructuring and other charges represent amounts incurred in connection with the elimination of redundant positions and facilities within the organization in connection with our LaunchPad initiatives ...
Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the fourth quarter of 2025 before the market opens on ...
LabCorp Enters Definitive Agreement to Acquire Monogram Biosciences, Inc. Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) and Monogram Biosciences, Inc. (NASDAQ: MGRM) today ...
Clients: Physicians, patients, biopharmaceutical companies, government agencies, managed care organizations, hospitals and clinical labs. Specialty testing group: Includes endocrine testing; ...
Ford, Sapient and Covance are among stocks to watch. MarketWatch's Tomi Kilgore has the details on the News Hub with Simon Constable. Photo: Getty Laboratory Corp. of America Holdings, one of the ...
Earlier this week, Labcorp Holdings Inc. declared a quarterly cash dividend of US$0.72 per share, payable on March 12, 2026 to shareholders of record as of February 27, 2026. In parallel, Labcorp ...
In my follow-up article on Labcorp, I am upgrading it to a 'Buy' this time. Macro forecasts and the firm's own portfolio growth of solutions and locations could drive more tailwinds to the top line.